Summit Place of Kings Mountain

The facility failed to ensure a resident was tested for tuberculosis disease in compliance with required control measures. Specifically, there was no documentation of a second-step TB skin test for one sampled resident.

The provided text is truncated and does not contain the specific findings for this violation.

The facility failed to ensure one of five sampled residents received a second-step TB skin test in compliance with required control measures. Documentation showed a negative test in January 2024, but no evidence of the required subsequent testing was present in the resident's record.

The facility failed to maintain an accurate electronic medication administration record (eMAR) for one of five sampled residents. Specifically, the facility failed to accurately document the administration of medications used to treat infections and parasites.

The facility failed to administer prescribed medications, specifically clonidine, vitamin D3, and lovastatin, as ordered for two residents. During an 8am medication pass, it was observed that Resident #8 had not received their weekly clonidine patch as required by physician orders.

The facility failed to administer prescribed medications, specifically clonidine, vitamin D3, and lovastatin, as ordered for two residents. For Resident #8, a weekly clonidine patch was missed because the facility failed to ensure the medication was available, and the error was not communicated to the appropriate staff until the next medication pass.